Skip to Content
  • Annual report 2022
    • Management review 2022
    • Small country, big agency
    • Fimea active in EU-level development work
    • A year of many legislative changes for Fimea and operators
    • Fimea has a strong role in pharmaceutical reform
    • Fimea continued to promote medication safety and safe pharmacotherapy
    • Drug advice provided in remote pharmacy services should be improved
    • A Finnish study: Safeguarding efficient antibacterial therapy calls for quick measures
    • Fimea develops services starting from the medical device operator and device register
    • Fimea’s customer satisfaction improved
    • Regulation of veterinary medicines also safeguards human health
    • Personnel training emphasises the sense of community
    • Fimea’s premises in Kuopio moved to Lake Kallavesi

 

  • Annual report 2022
    • Management review 2022
    • Small country, big agency
    • Fimea active in EU-level development work
    • A year of many legislative changes for Fimea and operators
    • Fimea has a strong role in pharmaceutical reform
    • Fimea continued to promote medication safety and safe pharmacotherapy
    • Drug advice provided in remote pharmacy services should be improved
    • A Finnish study: Safeguarding efficient antibacterial therapy calls for quick measures
    • Fimea develops services starting from the medical device operator and device register
    • Fimea’s customer satisfaction improved
    • Regulation of veterinary medicines also safeguards human health
    • Personnel training emphasises the sense of community
    • Fimea’s premises in Kuopio moved to Lake Kallavesi
  • Valitse kieli Suomi
  • Välj språket Svenska
  • Select language English

  • Management review 2022

  • Small country, big agency

  • Fimea continued to promote medication safety and safe pharmacotherapy

  • A year of many legislative changes for Fimea and operators

  • Fimea’s customer satisfaction improved

P.O. Box 55, 00034 FIMEA FI

029 522 3341

[email protected]

© Fimea 2023

Fimea promotes the health and safety of the population by regulating medicinal, medical devices, blood and tissue products, biobanks and by developing the pharmaceuticals sector.

Information about this website

  • Data protection (in Finnish)
  • Cookie policies
  • Accessibility statement